Review Article

Published in:
Volume 2 / Year 2013 / Issue 1

Biosimilars in the European market

Author(s): , , , , ,
Page: 30-5

Author byline as per print journal: Professor Joan Rovira, PhD; Leandro Lindner, BSc; Emmanuel Giménez, BSc; Professor Jaime Espín, PhD; Antonio Olry de Labry, PhD; Leticia García, BSc Introduction and… Read More »

Current status of biopharmaceuticals in Iran’s pharmaceutical market

Author(s):
Page: 26-9

Abstract: The clinical importance of biopharmaceuticals for the management of life threatening diseases is increasing but costs have become a major obstacle to the administration of these medicines, especially in… Read More »

Assessing biosimilarity and interchangeability of biosimilar products under the Biologics Price Competition and Innovation Act

Author(s): ,
Page: 20-5

Abstract: Biological (large molecule) drug products are made via living systems and are complex and variable in nature. As a result, generic forms of biological products, also termed biosimilars in… Read More »

Go Back Print